Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "Labiotech.eu" found in our extensive news archives from over 250 global news sources.
In addition to our news stories we have dozens of PubMed Articles about Labiotech.eu for you to read. Along with our medical data and news we also list Labiotech.eu Clinical Trials, which are updated daily. BioPortfolio also has a large database of Labiotech.eu Companies for you to search.
AELIX Therapeutics and Gilead will run a clinical trial testing a combination of treatments that has potential to let HIV-infected people ditch lifelong therapy. The trial, which will run in Spain, is planned to start in early 2019 and ... The post Spanish Biotech Partners Gilead to Develop Functional HIV Cure appeared first on Labiotech.eu.
We fly to Lomazzo, Italy, this week to visit Silk Biomaterials. As the name implies, the company is testing different medical applications of silk, such as in nerve repair. Mission: Founded in 2014, Silk Biomaterials uses silk as a scaffold ... The post This Biotech Spins Silk That Can Repair Nerves appeared first on Labiotech.eu.
The Italian biotech Cassiopea reports good news for acne sufferers. Its hormonal anti-acne treatment Winlevi significantly helped to reduce acne in two Phase III trials. Winlevi, when applied to the skin, cleared the acne in more than twice as many ... The post Phase III Triumph for Topical Hormonal Acne Treatment appeared first on Labiotech.eu.
Synpromics and UniQure have unveiled new technology for precise genetic control that could make gene therapy safer and more precise. The team has developed a gene therapy system that is highly selective for the liver. In a preclinical trial, it ... The post Liver Gene Therapy 8 Times Stronger Than Usual appeared first on Labiotech.eu.
Update (18/10/2018): Imlifidase has just been given Fast Track Designation by the FDA for application in transplantation. The designation should accelerate the treatment through the FDA’s regulatory process, with Hansa Medical hoping to apply for market authorization by early 2019. ... The post Update: Kidney Transplant Drug Gets FDA Priority appeared first on Labiotech.eu.
Update (18/10/2018): Imlifidase has just been given Fast Track Designation by the FDA for application in transplantation. The designation should accelerate the treatment through the FDA’s regulatory process, with Hansa Medical hoping to apply for market authorization by early 2019. ... The post Kidney Transplant Drug Gets FDA Priority appeared first on Labiotech.eu.
Syngulon will be developing antibacterial peptides using CRISPR/Cas9 gene editing technology thanks to an agreement with ERS Genomics, which licenses out CRISPR intellectual property in the EU. CRISPR technology is a hot topic in the biotech industry because it makes ... The post Belgian Firm Will Develop Antibiotic Alternatives for Industrial Biotech Using CRISPR appeared first on Labiotech.eu.
AbbVie’s Humira, a treatment for inflammatory disease and the world’s best-selling drug, is no longer patent-protected in the EU. Competitors are already taking advantage of it. Humira is an antibody drug, called adalimumab, that has been topping the lists of ... The post The EU Patent of the Best Selling Drug Has Expired, What Does it Mean for Biotech? appeared first on Labiotech.eu.
Hello biotechnologists, Time to leap into a new biotech job! Check out the position of Senior Scientist at Selvita or become the Marketing Manager at Bluebird Bio. Just starting out? Check out the Patent Attorney internship at NLO! Exclusive Offer DNA Synthesis Development ... The post Bite Down On These New Biotech Jobs appeared first on Labiotech.eu.
In recent years, our understanding of the human microbiome has reached an exciting momentum. It is no longer seen as a bunch of foreign invaders of the body, but rather more as a pseudo-organ that acts as a significant influencer ... The post Patenting Therapies in the Microbiome Field appeared first on Labiotech.eu.
A treatment developed by French biotech Pharnext has become the first clinically proven therapy for a rare genetic disorder that affects the nervous system. In a Phase III trial, the treatment reduced the level of disability of patients with Charcot-Marie-Tooth ... The post Drug Combination for Rare Genetic Nerve Disorder Nails Phase III appeared first on Labiotech.eu.
The Swedish biotech Immunicum has issued shares worth up to almost €34M on Nasdaq Stockholm, in an effort to accelerate the development of its cancer immunotherapy. Immunicum plans to use most of the funding to run a Phase Ib/II clinical ... The post Cancer Immunotherapy Biotech Raises €34M on Nasdaq Stockholm appeared first on Labiotech.eu.
The microbes living on our skin can play an important role in skin conditions such as acne. Philip talked to Veronika Oudova, CEO and co-founder of the Belgian company S-Biomedic, about how the company plans to fight acne with microbes, ... The post Using the Skin Microbiome to Treat Acne appeared first on Labiotech.eu.
Microsoft Genomics will work with Cambridge-based Eagle Genomics to scale up its artificial intelligence platform for microbiome research. In recent years, it has become evident that the microbes that inhabit our body are key to our health. The microbiome has ... The post Microsoft Signs its First Microbiome Partnership appeared first on Labiotech.eu.
If you are looking for an opportunity to pitch your startup, look no further. Here’s a guide to the key European events for biotech startup competitions. Taking part in a pitch competition can help a biotech company get a headstart ... The post The 6 Best Biotech Startup Competitions in Europe appeared first on Labiotech.eu.
These instruments are alive. Yeast, moss and paramecia are behind the unique sounds of Living Instruments, which will be performing a concert in Zurich on October 21st. Instead of strings or windpipes, the sounds of these instruments are generated by ... The post Living Instruments: Making Music with Yeast, Moss and Paramecia appeared first on Labiotech.eu.
In challenging times of climate change and a scarcity of resources, the European Commission has released a new strategy to boost activity and investment in companies contributing to the bioeconomy. As one of the key economies that signed the Paris ... The post European Commission Updates Strategy to Energize Europe’s Bioeconomy appeared first on Labiotech.eu.
While in Leuven, Belgium, for last week’s Biotech of the Week, we decided to go to the vet. ViroVet is a company aiming to improve viral disease control in livestock, which is a huge sector of global agriculture. Mission: To ... The post This Biotech is the First to Work on Antivirals for Farm Livestock appeared first on Labiotech.eu.
As well as helping you chew your hamburger, dentures could one day fight oral fungal infections, suggest researchers from Manchester Metropolitan University, UK. The population is getting older. In fact, it is predicted that almost half of Europe will be ... The post Rechargeable Dentures Could Prevent Mouth Infections appeared first on Labiotech.eu.
The German biotech Affimed has halted two Phase I trials of its cancer immunotherapy after three patients suffered neurotoxicity due to the treatment, causing the death of one of them. Affimed was testing its immunotherapy AFM11 in 33 patients diagnosed ... The post Cancer Immunotherapy Phase I on Hold After Patient Death appeared first on Labiotech.eu.
The British company Intelligent Fingerprinting has shown that its non-invasive fingerprint drug test can yield results comparable to blood tests in just 10 minutes. The technology, developed at the University of East Anglia, can detect extremely low amounts of amphetamines, ... The post This Test Can Detect Four Drugs With Just a Fingerprint appeared first on Labiotech.eu.
Making enough money to survive long enough to get a product to market can be tough for any biotech, but even more so for companies operating in the industrial space, where it can be less easy to predict development time ... The post How to Make Industrial Biotech Pay appeared first on Labiotech.eu.
The French biotech MedinCell, an injectable slow-release drug specialist, has received a shot of success as its IPO raises €30M in the Euronext stock exchange in Paris. MedinCell is hoping to improve patient compliance with medication regimes by injecting them ... The post Slow-Release Drug Biotech IPO Raises €30M appeared first on Labiotech.eu.
A European Phase III trial has become a major stress for British biotech Diurnal. Its specially designed hormone therapy was no better than conventional therapies in treating an inherited hormonal disorder. Congenital adrenal hyperplasia is a rare genetic condition where ... The post Hormone Therapy for Inherited Hormonal Disorder Fails at Phase III appeared first on Labiotech.eu.
Developing treatments for underserved diseases can be surprisingly profitable for biotechs, we asked the experts to tell us more about how best to exploit these areas. We hear a lot about cancer therapies or drugs to target heart disease in ... The post How to Capitalize on Opportunities in Underserved Disease Areas appeared first on Labiotech.eu.